Pharma's Market
SPECIAL REPORT
MOST SHARED
- Top 20 European Stocks for Crisis Time: Strategist
- Scots' Push for Britain Break-Up Begins in Earnest
- Why Are Greek and Italian Politicians So Bad?
- Both Campaigns Seize on Romney’s Years at Bain
- As Euro Meeting Fizzles Out, 2 Leaders Head Home to Tend Political Gardens
- Now Is the Time to Buy Chinese Stocks: Goldman Sachs
- Bargain Hunters and Aid Hopes Lift Europe Shares
- Australia Approves Migrant Workers for Mining Projects
- Beware Hidden Costs as Banks Eye ‘Grexit’
- Big European Funds Dump Euro Assets
- Curt Schilling's Video Game Company Goes Bust
- Time for Flash Sales to Adapt or Die
- What Flash Sites Are Suggesting About Consumers
- Hewlett-Packard Faces a ‘Dogfight’ for Talent: Analyst
- Laouchez: Leadership in Financial Services — Missing in Action?
- DuckDuckGo Cooks Google’s Goose: Analyst
- Growing Sub-Prime Auto Loans - New Troubles for Automakers?
- General Electric’s $4.5 Billion Dividend Slated for Buybacks
- Kuntz: Finding Opportunity in Emerging Markets
- Top 20 European Stocks for Crisis Time: Strategist
- Big European Funds Confirm Dumping Euro Assets
- Is 'Equity Cult' Dead? Stocks Most Unloved in 50 Years
- Scots' Push for Britain Break-Up Begins in Earnest
- Both Campaigns Seize on Romney’s Years at Bain
- Markets May End Week Quietly, With Wary Eye on Europe
- Heard in More US States: See You in Tax Court!
- Bankia Shares Suspended Ahead of Rescue Details
- Ukraine Lawmakers Get Into Huge Rumble — Again
RSS FEED
ImClone's New CEO: Already Repeating The Past?
Text Size 
Reporter
 |
Source: CNBC.com |
Recently I blogged about the hiring of a new CEO at ImClone [IMCL
Loading...
()
] Systems and the unique clause in his contract requiring him to buy half-a-million dollars worth of stock in the company. My suspicion was that ImClone Chairman and billionaire shareholder Carl Icahn had a hand in that. The contract states that John Johnson had to do the buy-in within three months of his start date which was August 27th. Well, he waited all of ten days.
ImClone's General Counsel, Daniel O'Connor, says Johnson came into some money from his former employer, Johnson & Johnson [JNJ
Loading...
()
] (presumably no relation), last week and that the very next day he wrote the big check to buy the shares straight from the company, not on the open market. An SEC filing says the trade was recorded last Friday, September 7th. He bought 13,609 shares for $36.74 apiece. Monday the stock closed at $37.93 and yesterday it shot up to nearly 45 bucks after the company's European partner on Erbitux, the German Merck (no connection to the American drug company) announced that the drug extended the lives of lung cancer patients. Today, the shares are up again.
But O'Connor says Johnson has to hold the stock for as long as he's CEO (he has a four-year contract) and then continue holding it for another year after he leaves the company. He also claims the timing of the trade and the clinical trial news is a coincidence. "This is simply a matter of John making the purchase when the money became available. No one at ImClone had prior knowledge as to whether the results would be favorable or unfavorable. Nor did we know when we'd receive the data. We were surprised to receive it on Monday," O'Connor told me over the phone.
ImClone's former CEO, Sam Waksal, is in prison for tipping off his family about bad news that sent the shares down. Martha Stewart, Waksal's friend (at least at the time), went to prison for lying to the feds about her sale of IMCL stock around the same time.
An SEC spokesman can't confirm or deny if the agency is or will be investigating the trade. But even though there may be nothing there, the timing of the trade and the company's history will likely raise some regulatory eyebrows and warrant a look-see. O'Connor says he hasn't heard from the SEC as of this morning.
I'll be blog-silent for a few days over the Jewish holiday and a weekend trip to Warren Buffett country to watch the USC Trojans beat the Nebraska Cornhuskers. A shout out to the CEO of Omaha-based TD Ameritrade, Joe Moglia, who hooked me up with two tickets that I'm buying for a reasonable price versus the top dollar they're going for on eBay and StubHub.
Questions? Comments?
Data is a real-time snapshot *Data is delayed at least 15 minutes
